Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2007; 13(5): 761-767
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.761
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.761
Table 3 Staging of the patients according to UICC
| UICC stage | n | No cirrhosis | Cirrhosis | Age (yr, mean ± SD) |
| I | 5 | 1 | 4 | 52 ± 11.7 |
| II | 13 | 1 | 12 | 60 ± 13.5 |
| III | 11 | 3 | 8 | 60.8 ± 8.0 |
| IV | 55 | 5 | 50 | 58 ± 11.6 |
| Total | 84 | 10 | 74 | 59 ± 11.4 |
- Citation: Obed A, Beham A, Püllmann K, Becker H, Schlitt HJ, Lorf T. Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation. World J Gastroenterol 2007; 13(5): 761-767
- URL: https://www.wjgnet.com/1007-9327/full/v13/i5/761.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i5.761